Domestic drug prices lower at 48% of 7 advanced countries.

Published: 2005-06-08 06:55:00

Updated: 2005-06-08 06:55:00

The Korea Pharmaceutical Manufacturers Association (KPMA) reported that the average price of the top 300 prescription drugs reimbursed by the NHI scheme in 2003 showed at the level of 48% of the 7 advanced countries in 2004, indicating that the domestic drugs were devalued at 32% in low and 63% i...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK